Commercial Opportunities

PharmaLinks provides opportunities for commercial developments in drug discovery and development. These include patented proprietary compounds, collaborative drug discovery programmes, and enabling technologies and expertise.

Our business model is flexible, and each programme can be specifically tailored to your requirements, giving access as necessary to stand-alone technology or to a multidisciplinary team with expertise in molecular pharmacology, in vitro and in vivo functional studies, and clinical experience. In addition, the management team within PharmaLinks has extensive experience of managing major projects and will ensure that results are delivered on time and within budget.

Licence and co-development opportunities

• compounds for prevention of restenosis
• drugs to reverse vascular damage associated with atherosclerosis, diabetes and pulmonary hypertension
• cognitive enhancers
• sedatives/hypnotics
• natural products with anti-diabetic properties
• anti-psoriasis compounds
• a therapeutic agent to combat contact lens-induced infection
• novel adjuvants
• novel drug delivery systems

• drug-eluting stents
• vascular targeting for gene therapy
• anti-obesity compounds
• novel anti-inflammatory compounds
• new targets for depression
• novel therapies for neurodegeneration
• therapeutic targets for diseases involving cognitive dysfunction
• respiratory diseases
• treatment of pulmonary hypertension

Expertise for tailor-made drug discovery collaborations

• cardiovascular diseases
• oncology
• chronic pain
• obesity and diabetes
• immunopharmacology
• infection
• parasitology

• AS/AGU rat: a model of Parkinson's disease
• animal models of cardiovascular disease
• animal models of respiratory disease
• natural products for drug discovery screening
• synthetic and medicinal chemistry
• formulation and drug delivery
• functional imaging
• biostatistics
• epidemiology 
• virtual screening service